CAS: 1502816-23-0

MS 049 is a potent, selective, and cell-active dual inhibitor of PRMT4 and PRMT6 with IC 50 of 34 nM and 43 nM, respectively.

2-(4-(Benzyloxy)Piperidin-1-Yl)-N-Methylethanamine

MS049

MS049 is an inorganic compound that is used for the treatment of cancer. It is a basic protein and has been shown to bind to DNA-bound proteins and to regulate gene expression. MS049 binds specifically to methyltransferases, which are enzymes that regulate the methylation of arginine residues in proteins. These methylation changes can have a regulatory effect on the cell cycle, leading to apoptosis or cellular differentiation. MS049 has also been shown to be effective against cardiovascular diseases and carcinoma cells.